Novo Nordisk Launches Wegovy Weight Loss Drug in China

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Business - The Wall Street Journal - 13 hours ago

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Top stories - CBS News - November 3

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Novo Nordisk's Wegovy Sales Beat Expectations

The pharmaceutical giant’s blockbuster weight-loss drug beat sales expectations in the third quarter, sending shares higher in early trade.

Business - The Wall Street Journal - November 6

Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.

Business - CNBC - November 6

Novo Nordisk's obesity-fighting drugs fatten Denmark's economy

Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.

Top stories - CBS News - November 3

Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for those manufacturers to make safely.

Business - CNBC - October 23

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.

Business - CNBC - October 30

Not just for weight loss: Wegovy may help curb alcohol addiction

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.

Business - CNBC - October 24

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - 5 days ago

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - 3 days ago

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - 16 hours ago

With Novo Nordisk success, is there a "Nokia risk" for Denmark?

Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.

Top stories - CBS News - November 3

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - October 24

Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - 6 days ago

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

Science - The New York Times - 5 days ago

Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients

The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

Business - The Wall Street Journal - October 21

Ozempic maker Novo Nordisk nudges higher profit forecast

Novo Nordisk on Wednesday nudged higher its outlook for the year as the drugmaker registered another quarter of strong sales of its weight-loss drugs.

Business - MarketWatch - November 6

Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Politics - The Hill - October 23

How a love story launched the company behind Ozempic, Wegovy

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.

Top stories - CBS News - November 3

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - October 30

Hoping for a weight-loss pill? It could get closer to reality next week.

Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event.

Business - MarketWatch - November 2

Mother-of-two dies during Turkey weight-loss op

Janet Savage paid £2,750 for the procedure but stopped breathing during surgery.

AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.

Business - MarketWatch - November 5

Latest in Novo Nordisk Launches Wegovy Weight Loss Drug in China